Latest News for: hikma
Edit
Inspired at Hikma: Building partnerships for growth and to meet patient needs. Meet Lama Shatara, Sr. Director, Business... (Hikma Pharmaceuticals plc)
Public Technologies 05 Oct 2026
Edit
Hikma signs exclusive licensing and distribution agreement with Dr. Reddy's Laboratories for Nicotinell across MENA
Zawya 29 Sep 2026
Through this strategic ...
Edit
Hikma R&D Investor Spotlight Series (Hikma Pharmaceuticals plc)
Public Technologies 22 Sep 2026
London, Tuesday 22 September 2026 - Hikma Pharmaceuticals PLC ('Hikma' or 'Group'), the multinational pharmaceutical company, today announces it will host a series of three educational investor ...
Edit
R&D at Hikma | Meet Dima Freihat, helping bring medicines from development to manufacturing (Hikma Pharmaceuticals plc)
Public Technologies 16 Sep 2026
) ... How would you describe working at Hikma?. Working at Hikma is both challenging and rewarding ... Disclaimer. Hikma Pharmaceuticals plc published this content on September 16, 2026, and is solely responsible for the information contained herein ... (noodl.
Edit
Hikma launches Glucentra® as the first generic semaglutide available to patients in Saudi Arabia (Hikma Pharmaceuticals plc)
Public Technologies 16 Sep 2026
London, 16 September 2026 - Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces the launch of Glucentra® (semaglutide) the first generic version of Ozempic® ...
Edit
Empowered at Hikma | Meet Ana Catarina Costa, Sr. Manager, Regulatory Affairs, Hikma Portugal (Hikma Pharmaceuticals plc)
Public Technologies 10 Sep 2026
At Hikma, our people are the driving force behind the impact we make for patients and communities around the world. Empowered at Hikma is a series that shines a spotlight ...
Edit
Hikma advances its epinephrine nasal spray with multi-market regulatory filings (Hikma Pharmaceuticals plc)
Public Technologies 09 Sep 2026
Edit
Hikma launches Diazepam Injection, USP in the US (Hikma Pharmaceuticals plc)
Public Technologies 08 Jul 2026
London, UK, 8 July 2026 - Hikma Pharmaceuticals PLC (Hikma, Group), a multinational pharmaceutical company, today announced the launch of Diazepam Injection, USP, C-IV, 5 mg/mL (10 mg/2 mL), in 2 mL ...
Edit
Hikma launches XCOPRI® (Cenobamate tablets) in the UAE (Hikma Pharmaceuticals plc)
Public Technologies 06 Jul 2026
Edit
Hikma Donates $1 Million in Emergency Medicines for Venezuela Earthquake Relief
Petra 05 Jul 2026
Amman, July 5 (Petra) -- Hikma Pharmaceuticals has donated an emergency shipment of medicines worth $1 million to support relief efforts for people affected by the recent twin earthquakes in Venezuela, the company announced on Sunday.
- 1